ABSTRACT
the cell surface. Although cells expredng Nef-1 also induce calcium mobilization and the production of IL-2 receptor a chain, the formation of IL-2 mRNA is blocked in response to these stimuli. Moreover, Nef-1-expressing cells trpasfected with a plasmid in which the IL-2 promoter is fused to the chloramphenicol acetyltransferase (CAT) gene fail to induce CAT following treatment with PMA and PHA. By contrpst, the parental and Nef-2-containing cells induce CAT normally. Nef-1-expressing cells can produce IL-2 mRNA in response to a combination of PMA and ionomycin, although much less efnciently than the parental Jurkat cells or Nef-2sxpressing cells. These LIndings, and others described herein, suggest that the virally encoded Nef protein interferes with a signal emanating from the T-cell receptor complex that induces IL-2 gene transcription.
activation of a variety of lymphokine genes, including the interleukin 2 (IL-2) gene. These lymphokines are required both for the clonal expansion of the antigen-reactive T cell and for the efficient recruitment of other hemopoietic cells involved in the immune response.
Nef has been reported to bind GTP and to be a GTPase (14, properties it shares with the a subunits of trimeric G proteins and with Ras proteins, molecules which have known roles in signal transduction. Moreover, like members of the Src family, which are also involved in signal transduction, Nef is myristoylated at its N terminus and is associated with membranes (15, 16) . These properties prompted us to determine whether Nef affects a T cell's ability to transduce the correct signal upon antigen binding. We reasoned that interference with signal transduction in HIV-1-infected T cells could potentially alter the levels of lymphokine production and might be expected to have profound effects upon the immune response.
Our results show that T cells constitutively expressing one form of Nef (Nef-1) are severely impaired in their ability to produce IL-2 mRNA in response to agents that mimic antigen binding to the antigen receptor. By contrast, cells that express Nef-2, which differs in three amino acids from Nef-1, induce IL-2 mRNA normally following the antigenic stimulus. Additional comparisons of the properties of Nef-1-and Nef-2-producing cells with their parental cells are also discussed.
Type 1 human immunodeficiency virus (HIV-1) contains seven genes (tat, rev, tev, vpu, vpr, vif, and nef) in addition to the signatory retroviral genes gag, pol, and env. Some of these genes have clearly established functions (l), whereas others are less well understood. The nef gene product (Nef protein), for example, is not required for HIV-1 multiplication in tissue culture cells (2, 3); indeed, viruses with defective nef genes replicate marginally more efficiently than the wild-type virus (3). Moreover, relative to their nontransformed parental cells, T cells stably transformed for nef expression exhibit a delay in viral multiplication following introduction of HIV-1 by infection or DNA transfection (4).
Initially, Nef was thought to down-regulate transcription from the viral LTR (5, 6) , but recent studies make this problematic (7-9).
Rather than concentrate on the role of Nef in the viral life cycle, we have investigated the effect of nef expression on host cell functions. The major cell targets for HIV-1 infection are CD4+ T cells (10-12), most of which constitute the T-helper class (13). These CD4+ T-helper cells bind antigen in the context of class I1 products of the major histocompatibility complex and consequently induce the transcriptional The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. $1734 solely to indicate this fact.
MATERIALS AND METHODS

Construction of Nef Expression
Hasmids. Full details of the construction of Nef expression plasmids, which were constructed by standard techniques (17), will be published elsewhere. A brief outline is provided in the legend to Fig. 1 .
Preparation of Anti-Nef Antibodies. Polyclonal Nef antibodies were obtained from New Zealand White rabbits that had been injected with a TrpE-Nef fusion protein made in Escherichia coli. The nefgene from pNLA32 ( 5 ) was amplified by the polymerase chain reaction using oligonucleotides spanning the coding sequence (21). The resulting nef DNA was cloned into PATH1 (22) to give a trpE-nefgene fusion. The TrpErNef fusion protein, produced after induction (22). was purified twice by PAGE and a gel slice containing the protein was used to immunize rabbits. After bleeding, the serum was used without further purification.
Cell Culture and Production of nef Transformants. The Jurkat human T-cell line J25 (obtained from G. Crabtree, Stanford University) was maintained in RPMI 1640 with 10% fetal bovine serum and penicillin (500 units/ml)/streptomy- cin sulfate (100 pg/ml) in a 5% C 0 2 atmosphere. Nefexpressing cell lines were isolated after electroporation (23) ofJ25 cells(1.6 x lO'cellsin0.8ml) with72pgofNefplasmid ( Fig. 1 ) and 7 pg of either pSV2neo (24) or pSV2hph. The transfected cells were divided among 24-well dishes and grown for 40 hr before the addition of G418 (800 pg/ml) or hygromycin (50 pg/ml). In the latter selection, the hygromycin concentration was kept at 50 pg/ml for 1 week and then increased by 50 pg/ml every 2 days to a final concentration of 300pg/ml. After about 3 weeks, cells from individual wells were screened for Nef expression by Western immunoblotting (25). Cells from positive wells were cloned, using a fluorescence-activated cell sorter, into %-well dishes containing selective medium with 20% fetal bovine serum. Western blotting was used to identify Nef-expressing clones.
T-cell Activation. Cells from exponentially growing cultures were activated by resuspension in fresh medium containing phorbol 12-myristate 13-acetate (PMA, 20 ng/ml; Sigma) and either phytohemagglutinin (PHA, 2 pg/ml; Sigma), anti-CD~E antibody OKT3 (1 pg/ml; Becton Dickinson), anti-T-cell receptor (TCR) antibody C305 dilution of ascites fluid provided by Arthur Weiss, University of California, San Francisco), anti-CD2 antibodies 101d2-4Cl and lmono-2A6 (lo-' dilution of ascites fluid provided by Ellis Reinherz, Harvard Medical School), or ionomycin (2 pM; Calbiochem) and incubation at 37°C. The response to T-cell activation was monitored as indicated in the figure legends.
RESULTS
IdentiTication of Nef-Expressing Cell Lines. Stable cell lines expressing Nef were identified by immunoblotting extracts obtained from cells harvested during logarithmic growth (Fig.  2) . The mobility of the protein reacting with the anti-TrpENef antiserum in the various clones is consistent with the 27-kDa size of Nef reported by others (4, 8, 9, 14, 16) . Twelve independent cell lines expressing Nef were obtained; eight of these were derived from transfections with SRanef-1, while the remaining four were from transfections with SRanef-2 ( Fig. 1) . Several drug-resistant clones were also recovered that failed to express Nef (clones 1OC3 and 6B6, Fig. 2 ); these cells also lacked nef DNA as judged by Southern blotting. Despite the fact that cotransfections were performed using a 10-fold excess of nefplasmid relative to neo plasmid, Nef expressing clones were rarer than expected. In fact, the majority of drug-resistant clones did not contain detectable Nef, and those that did contained one or at most three copies of nef. Perhaps high levels of Nef are cytotoxic.
CeUs Expressing Net-1 Fail to Produce IL-2 mRNA in
Response to T-cell Activation. The T-cell's antigen receptor (TCR) normally responds to ligand binding by inducing the synthesis of a variety of cytokines. Of the several cytokines that can be induced in the Jurkat T-cell line, the induction of IL-2 mRNA is the best characterized (26). Therefore, we compared cells expressing or not expressing Nef for their response to PMA and PHA, agents known to induce IL-2 production through the TCR pathway (27).
Because IL-2 mRNA production in Jurkat cells reaches a maximum =4 hr after the addition of PMA and PHA, that time was chosen to measure the response of the various Nef-expressing clones. Fig. 3 Fig. 2. (A) Autoradiogram of the filter hybridized to the IL-2 probe: 1L-2 mRNA migrates faster than the 18s rRNA. ( E ) Photograph of the ethidium bromide-stained gel from which the blot shown in A was obtained.
Nef-1 and two of the Nef-2 clones with PMA and PHA. Clones expressing Nef-1 were severely inhibited in their ability to accumulate IL-2 mRNA, whereas the Nef-2-expressing clones responded normally. This apparent failure of the Nef-1 clones to induce IL-2 mRNA was not due to an alteration in the kinetics of its accumulation, because IL-2 mRNA was not detectable between 5 min and 24 hr after induction. Furthermore, treatment with a combination of doses of PHA and PMA up to 5 pg/ml and 200 ng/ml, respectively, failed to induce IL-2 mRNA, indicating that the failure to respond was not due to an altered doseresponsiveness. Nef-1-expressing cells were equally unable to induce IL-2 mRNA when PMA was coupled with the more specific stimulation provided by monoclonal antibodies directed against either the TCR p chain, CD3.5, or CD2, whereas the Nef-Zexpressing cells responded as well as the parental Jurkat cells. None of the clones synthesized IL-2 mRNA without induction.
Three Nef-1-expressing clones were exceptional. One clone, 14E6, which contains barely detectable levels of Nef as judged by immunoblotting, induces IL-2 mRNA normally after PMA and PHA treatment. Thus, the block in IL-2 induction may depend upon the level of Nef. Clone 5B2 expresses Nef-1 at a level equivalent to those shown in Fig.  2 yet it expresses IL-2 mRNA normally in response to induction. Further studies of this clone's properties are needed to resolve this exception. Clone 6C2, which expresses Nef-1, does not induce IL-2 mRNA. However, because 6C2 lacks surface CD3 expression (data not shown), its failure to induce IL-2 mRNA is not necessarily attributable to the presence of Nef-1.
Calcium Ionophore Partially Alleviates the Block to E -2 mRNA Production in Nef-Expressing T Cells. Calcium ionophores can bypass the requirement for ligand binding to the TCR for 1L-2 production (27). Consequently, we tested whether ionomycin in combination with PMA could induce IL-2 mRNA in Nef-expressing cells. Northern blots of the RNA obtained after induction of the Nef-expressing clones showed that all of the Nef-2-expressing clones, two of which are shown in Fig. 4 , induced IL-2 mRNA as efficiently as was present on the cell surface prior to the addition of PMA and PHA, flow cytometry showed that IL-2Ra on the cell surface increased following induction, reaching a maximum =24 hr postinduction (data not shown).
Nef-1 Blocks Transcription from the IL-2 Promoter in
Induced T Cells. The ability of the Nef-1-expressing clones to induce calcium mobilization and IL-2Ra formation in response to TCR activation suggests that the cells are not in a generalized nonresponsive state. Therefore, we tested whether the block in IL-2 mRNA induction in Nef-1 expressing cells stems from the IL-2 gene promoter's inability to respond to TCR stimulation. For that purpose, Nefexpressing cells were compared with Jurkat cells for their ability to express chloramphenicol acetyltransferase (CAT) after transfection with a plasmid containing an IL-2 promoter-CAT gene fusion (32) and stimulation with PMA and PHA. CAT expression from the IL-2 promoter was markedly impaired in the Nef-1-expressing cells compared with Jurkat and Nef-Zexpressing cells (Fig. 5 , open bars) . Similar indications that IL-2 promoter activation is impaired by Nef-1 were obtained when Jurkat cells were cotransfected with the IL-2-CAT gene and a nefplasmid and then induced with PMA and PHA (Fig. 5) . SRanef-1 caused a reproducible 50-60% inhibition of CAT expression compared with SRanef-2 or the control plasmid SRanef-*; essentially the same degree of inhibition of CAT expression was observed when the same cotransfections were made into Nef-2-expressing cells (Fig. 5) . That CAT production is not more
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UMCAT + puc FIG. 5 . Nef-1 impairs IL-2 promoter inducibility. Cells (lo') from exponentially growing cultures were transfected by a modification of the DEAE-dextran method (33) with 22 pg of a 5 5 1 mixture of the indicated plasmid, the IL-2-CAT gene, and a Rous sarcoma virus promoter-luciferase gene construct. Forty hours after transfection, cultures were induced with PHA and PMA and after a further 12 hr cell extracts were prepared and assayed for CAT activity over an 18-hr incubation (34) . CAT activities, expressed as percent conversion of chloramphenicol to its acetylated derivatives per 200 pg of protein after correction for luciferase activity, are the mean ofat least three independent experiments; standard deviations are indicated by bars. severely blocked by the cotransfected SRanef-1 could be due to some cells receiving only the IL-2-CAT plasmid. SRanef-* does not produce protein recognized by the anti-TrpENef antiserum following transfection into COS cells (data not shown) and was therefore used to control for possible effects of SRanef DNA or RNA sequences upon IL-2-CAT expression. Taken together, these experiments indicate that cells expressing Nef-1 are impaired in IL-2 promoter function in response to TCR activation.
Although Nef-2 fails to block IL-2 transcription after TCR activation, it can antagonize the inhibitory behavior of Nef-1. Thus, cotransfection of Nef-1-expressing cells with SRanef-2 and the I L -2 4 A T gene resulted in a nearly 10-fold induction of CAT formation following treatment with PMA and PHA (Fig. 5) .
DISCUSSION
We explored the possibility that the HIV-1 nefgene product (Ne0 affects an essential T-cell function rather than being needed for viral replication. To test that notion, nef was stably introduced into Jurkat T cells under the transcriptional control of a constitutive promoter. Two nef genes were examined: one ( n e f l ) encodes a protein with alanine, glycine, and valine at positions 15,29, and 33, respectively, and the second (nef-2) differs only by encoding threonine, arginine, and alanine at the corresponding positions. Cells expressing either Nef-1 or Nef-2 were compared to the parental untransformed cells for their responses to agents known to mimic T-cell activation via the TCR.
Normal Jurkat cells and each of four independent clones expressing Nef-2 respond promptly to several stimuli known to induce IL-2 mRNA: PMA in combination either with PHA or with antibodies to CD3.5, TCR j3 chain, or CD2, or with ionomycin. By contrast, five of eight independent Nef-lexpressing clones appear to be unable to induce 1L-2 mRNA after treatment with PMA in combination with any of the above mentioned external ligands. Because treatment of the unresponsive Nef-1-expressing clones with PMA and the calcium ionophore ionomycin results in a weak-to-moderate induction of IL-2 mRNA, we surmise that the IL-2 gene is still functional. Three of the eight Nef-1-expressing clones were exceptions. One (6C2) lacked CD3 and, therefore, its failure to induce IL-2 upon receptor activation cannot necessarily be attributed to the presence of Nef-1. Another (14E6) responds normally to receptor activation but it expresses considerably lower levels of Nef-1, suggesting that the amount of Nef-1 may be important for its inhibitory activity. The remaining exceptional clone (5B2) needs further study to explain its phenotype.
Mobilization of calcium and formation of the high-affinity IL-2 receptor are both well-documented additional inducible responses following TCR stimulation (27, 30 ). Yet, despite the failure of most Nef-1-expressing cells to produce IL-2 mRNA in response to TCR activation, the cells induce IL-2Ra and mobilize intracellular calcium normally. This indicates that only some of the signal-transduction pathways induced via the TCR complex are abolished or inhibited by Nef-1.
We surmise that the inability of Nef-1-expressing cells to induce IL-2 mRNA production by TCR activation stems from a block in the activation of the IL-2 gene promoter. This follows from our finding that an IL-2 promoter-driven CAT gene fails to be expressed after transfection into Nef-lexpressing cells following activation with PMA and PHA. By contrast, nearly equal levels of CAT are expressed in the parental Jurkat and Nef-2-expressing cells in comparable transfections. This result implicates the IL-2 gene promoter as a target of the Nef-1 inhibitory effect.
An important consideration relevant to our interpretation of the action of Nef is whether the cell's inability to induce IL-2 expression results from the presence of Nef per se or from some unknown property of the selected clones. The results obtained in experiments where the parental Jurkat cells were cotransfected with plasmids containing the IL-2-CAT gene and either of the two SRanef genes, and then induced with PMA and PHA, clearly implicate Nef-1 as the activity responsible for blocking the induction of IL-2. Plasmids comparable to the SRanef-1, in which the n e f l sequence is replaced by nef-2 or nef-*, have little or no effect on IL-2 induction. This finding indicates that Nef-1, but not Nef-2, prevents the induction of IL-2 following TCR activation. It will be particularly interesting to determine the structural basis for the functional difference between Nef-1 and Nef-2.
A further indication that Nef-1 is the activity responsible for the block to IL-2 induction comes from similar cotransfection experiments of the Nef-1-expressing cells. Here, cotransfection of IL-2-CAT and SRanef-2 genes rescued the CAT inducibility of the Nef-1-expressing cells, whereas no such effect was observed when SRanef-2 was replaced by SRanef-1 or SRanef-*. This indicates that Nef-2 can compete with Nef-1 for interaction with a critical component of the IL-2 induction pathway and that in doing so it relieves the inhibitory effect of Nef-1. Mutagenesis of Nef-2 should help define the regions important for this competition.
Previous studies have suggested that Nef acts to decrease viral multiplication (3-6). (26) . The nature of the molecules and reactions involved in that signal transduction is poorly understood, but activation ofthe TCR by treatments similar to the ones we have used has been found to induce a rapid conversion of RasGDP to RasGTP (36). Nef has limited but significant homology to the nucleotide-binding domains of Ras and G a proteins and has been reported to bind GTP and to act as a GTPase (14). Although intracellular calcium is mobilized normally following TCR activation of Nef-1 cells, the block in IL-2 induction may nevertheless be influenced by the intracellular calcium level. This follows from our finding that the considerably greater rise in intracellular calcium produced by ionomycin is able to partially alleviate the Nef-1-mediated block of IL-2 production.
The phenotype of the Nef-1-expressing cells bears a striking similarity to the phenotypes observed in three recently described cases of severe combined immunodeficiency in human infants (37-40). In each of these cases, stimulation of the patient's peripheral blood lymphocytes with a variety of external ligands failed to induce IL-2 mRNA, despite being accompanied by the normal IL-2Ra induction and, where examined (37, 39), the normal rise in intracellular calcium concentration. Furthermore, the defect in these individuals may lie on the same pathway as that affected by Nef-1, since treatment of the cells with phorbol ester and calcium ionophore induced low levels of IL-2 mRNA in two of the cases (37, 40).
That cells expressing Nef-1 seem to be unable to produce IL-2 in response to TCR stimulation is of direct significance to the pathogenesis of AIDS. Because IL-2 binding to the high-affinity IL-2 receptor is necessary for cell division and therefore clonal expansion of the antigen-reactive cell, a T cell that fails to induce IL-2 in response to antigen is functionally absent from the individual's repertoire. But because Nef-expressing cells can induce ILZRa, they can continue to divide as long as there is sufficient IL-2 made by cells whose signal-transduction system is functional. However, as the number of Nef-expressing cells increases, the amount of adventitious IL-2 available for clonal expansion of an antigen-stimulated Nef-containing cell would decrease, leading ultimately to the T-cell population's demise. 
